Lilleri et al., 2008 - Google Patents
Human cytomegalovirus-specific memory CD8+ and CD4+ T cell differentiation after primary infectionLilleri et al., 2008
View HTML- Document ID
- 1077861245873798715
- Author
- Lilleri D
- Fornara C
- Revello M
- Gerna G
- Publication year
- Publication venue
- The Journal of infectious diseases
External Links
Snippet
Background. The development of human cytomegalovirus (HCMV)-specific T cell immunity after primary infection and its correlation with virus transmission to the fetus were investigated. Methods. The membrane phenotype (CCR7 and CD45RA expression) of and …
- 241000701024 Human betaherpesvirus 5 0 title abstract description 174
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lilleri et al. | Human cytomegalovirus-specific memory CD8+ and CD4+ T cell differentiation after primary infection | |
| Lilleri et al. | Development of human cytomegalovirus—specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus | |
| Harari et al. | Cytomegalovirus (CMV)-specific cellular immune responses | |
| Mason et al. | Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4+ T cells | |
| Björkström et al. | Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus | |
| Halary et al. | Shared reactivity of Vδ2neg γδ T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells | |
| Kobie et al. | T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine | |
| Yang et al. | Application of the ELISPOT assay to the characterization of CD8+ responses to Epstein-Barr virus antigens | |
| Palendira et al. | Primary immunodeficiencies and the control of Epstein–Barr virus infection | |
| Macedo et al. | EBV-specific CD8+ T cells from asymptomatic pediatric thoracic transplant patients carrying chronic high EBV loads display contrasting features: activated phenotype and exhausted function | |
| van Baarle et al. | Significance of senescence for virus-specific memory T cell responses: rapid ageing during chronic stimulation of the immune system | |
| Huygens et al. | Functional exhaustion limits CD4+ and CD8+ T-cell responses to congenital cytomegalovirus infection | |
| Lugthart et al. | Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation | |
| Fornara et al. | Kinetics of effector functions and phenotype of virus-specific and γδ T lymphocytes in primary human cytomegalovirus infection during pregnancy | |
| Pietersma et al. | Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients | |
| Dauby et al. | Primary human cytomegalovirus infection induces the expansion of virus-specific activated and atypical memory B cells | |
| Gabanti et al. | Human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells are both required for prevention of HCMV disease in seropositive solid-organ transplant recipients | |
| Berner et al. | Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE | |
| Callan | The immune response to Epstein–Barr virus | |
| Guérin-El Khourouj et al. | Quantitative and qualitative CD4 T cell immune responses related to adenovirus DNAemia in hematopoietic stem cell transplantation | |
| Revello et al. | Lymphoproliferative response in primary human cytomegalovirus (HCMV) infection is delayed in HCMV transmitter mothers | |
| Gibson et al. | Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection | |
| Maecker et al. | Analyzing T-cell responses to cytomegalovirus by cytokine flow cytometry | |
| Alejenef et al. | Cytomegalovirus drives Vδ2neg γδ T cell inflation in many healthy virus carriers with increasing age | |
| Lam et al. | Co-infection of cytomegalovirus and Epstein-Barr virus diminishes the frequency of CD56dimNKG2A+ KIR− NK cells and contributes to suboptimal control of EBV in immunosuppressed children with post-transplant lymphoproliferative disorder |